Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pyrimidine nucleoside phosphorylase gene and application thereof

A pyrimidine nucleoside phosphorylase gene and a pyrimidine nucleoside phosphorylase technology are applied to the pyrimidine nucleoside phosphorylase gene and its application fields, and can solve the problems of small amount of enzyme and the like

Active Publication Date: 2016-03-16
JIANGSU ALPHA PHARM CO LTD
View PDF1 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the use of natural strains containing nucleoside phosphorylase to synthesize nucleoside drugs has the disadvantage of a small amount of enzymes, and the construction of genetically engineered bacteria can solve the problem of enzyme amounts

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pyrimidine nucleoside phosphorylase gene and application thereof
  • Pyrimidine nucleoside phosphorylase gene and application thereof
  • Pyrimidine nucleoside phosphorylase gene and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] The establishment of embodiment 1 genetically engineered bacteria

[0034]According to the Escherichia coli pyrimidine nucleoside phosphorylase gene (Genbank: NC_000913.3) announced by Genebank, the pyrimidine nucleoside phosphorylase gene fragment was artificially synthesized, and the gene fragment was used as a template to expand the fragment by PCR amplification (on both sides of the fragment) plus BamHI and EcoRI endonuclease fragments), its nucleotide sequence is shown in SEQ ID NO.3 (Genbank: NC_000913.3). And the gene was inserted into the pET-28a(+) plasmid by using the HindⅢ and BamHI endonuclease sites, and the ligated vector was transferred into Escherichia coli BL21(DE3) to establish the pyrimidine nucleoside phosphorylase genetically engineered bacteria. The primers for PCR amplification of the pyrimidine nucleoside phosphorylase gene are as follows: the upstream primer is 5'-GTCTGATGTTTTTCATCTCG-3' (SEQ ID NO.4), and the downstream primer is 5'-CCCGTTTTCCC...

Embodiment 3

[0044] The shaking flask culture of embodiment 3 recombinant escherichia coli

[0045] The recombinant Escherichia coli E.ColiBL21NP1506 obtained in Example 2 was inoculated into 50 mL of LB medium containing kanamycin (30 μg / mL) (peptone 10 g / L, yeast extract 5 g / L, NaCl 10 g / L, pH7. 0), cultured at 37°C for 6 hours in a shaker at 200 rpm. Transfer 3% bacterial cell culture solution to a 250 mL shake flask equipped with LB medium (containing 30 μg / mL kanamycin), and culture under the same conditions with shaking. When the OD600 value of the bacterial solution reaches about 0.6, add the inducer isopropyl βD-thiogalactopyranoside (IPTG) to a final concentration of 0.1mmol / L, and place the culture solution in a shaker at 28°C and 200rpm to induce Express for 6 hours. After expression, the cells were collected by centrifugation (8000rpm, 10min, 4°C), washed twice with phosphate buffer (pH7.5, 10mmol / L), dispersed in the same pre-cooled buffer, and ultrasonicated in an ice-water...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the fields of biotechnology and biological medicine, in particular to a pyrimidine nucleoside phosphorylase gene and the application thereof. The nucleotide sequence of the pyrimidine nucleoside phosphorylase gene is shown in SEQ ID NO.1, and the amino acid sequence of pyrimidine nucleoside phosphorylase coded by the gene is shown in SEQ ID NO.2. A genetically engineered bacterium containing the gene is obtained by transferring the gene into escherichia coli. By culturing the genetically engineered bacterium and optimizing the fermentation technology, large-scale production of recombined pyrimidine nucleoside phosphorylase is achieved, and the recombined pyrimidine nucleoside phosphorylase can be used for catalyzed synthesis of Sofosbuvir midbody (2'R)-2'-deoxygenation-2'-fluorine-2'-methyl uridine and production of other nucleoside bulk pharmaceutical chemicals and medical intermediates.

Description

technical field [0001] The invention belongs to the field of biotechnology and biomedicine, and relates to a pyrimidine nucleoside phosphorylase gene and its application, in particular to a class of pyrimidine nucleoside phosphorylase and its gene, and a recombination containing the pyrimidine nucleoside phosphorylase gene Expression vector and genetic engineering bacteria, and used to catalyze the synthesis of sofosbuvir intermediate (2'R)-2'-deoxy-2'-fluoro-2'-methyluridine, and other nucleoside APIs and medicines Production of intermediates. Background technique [0002] Sofosbuvir (trade name Sovaldi) is an oral treatment drug for hepatitis C (HCV) developed by GileadSciences in the United States. It was approved for marketing by FDA in December 2013. Sofosbuvir is the first drug approved for the full oral treatment of hepatitis C, and the world's first marketed HCV polymerase nucleoside inhibitor, which interferes with the viral genetic material RNA by acting on the HC...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/54C12N9/10C12N15/70C12N1/21C12P19/38C12R1/19
CPCC12N9/1077C12P19/385C12Y204/02002
Inventor 陈峻青石利平尹晓龙
Owner JIANGSU ALPHA PHARM CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com